Under pressure from Trump administration, FDA ignores lack of evidence to expand use of remdesivir to all patients

im
Remdesivir. Credit: Yonhap News/Zuma Press

[August 28, the FDA] allowed the drug remdesivir to be used on all patients hospitalized with COVID-19, although no published research supports such widespread use.

The approval allows doctors freedom to prescribe the antiviral earlier. But it comes less than a week after the agency approved use of convalescent plasma without published scientific support, fueling concerns the agency is yielding to political pressure.

“It seems to be a pattern of approval without science, without data, without evidence,” said Dr. Eric Topol, vice president for research at Scripps Research.

In May, the FDA issued an emergency use authorization for a drug called hydroxychloroquine, which was strongly promoted by President Donald Trump. There was little data supporting the approval, and the FDA reversed its decision in June after mounting evidence suggested the drug did more harm than good.

Related article:  CRISPR-based diagnostic tools will be able to rapidly diagnose future pandemics
Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

For decades the FDA has set the world’s standard for drug approvals. Although it has been criticized before for yielding to political pressure, those who follow the agency said they have never seen such consistent politicization.

Topol and others said they are particularly concerned about the FDA because the public needs to have faith in the agency that will approve any COVID-19 vaccine.

Topol said he fears it may be too late to preserve the FDA’s credibility. “For the public that’s paying attention, it’s already been sacrificed,” he said.

Read the original post

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Video: Test everyone – Slovakia goes its own way to control COVID

Video: Test everyone – Slovakia goes its own way to control COVID

As Europe sees record coronavirus cases and deaths, Slovakia is testing its entire adult population. WSJ's Drew Hinshaw explains how ...
mag insects image superjumbo v

Disaster interrupted: Which farming system better preserves insect populations: Organic or conventional?

A three-year run of fragmentary Armageddon-like studies had primed the journalism pumps and settled the media framing about the future ...
dead bee desolate city

Are we facing an ‘Insect Apocalypse’ caused by ‘intensive, industrial’ farming and agricultural chemicals? The media say yes; Science says ‘no’

The media call it the “Insect Apocalypse”. In the past three years, the phrase has become an accepted truth of ...
globalmethanebudget globalcarbonproject cropped x

Infographic: Cows cause climate change? Agriculture scientist says ‘belching bovines’ get too much blame

A recent interview by Caroline Stocks, a UK journalist who writes about food, agriculture and the environment, of air quality ...
organic hillside sweet corn x

Organic v conventional using GMOs: Which is the more sustainable farming?

Many consumers spend more for organic food to avoid genetically modified products in part because they believe that “industrial agriculture” ...
benjamin franklin x

Are most GMO safety studies funded by industry?

The assertion that biotech companies do the research and the government just signs off on it is false ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies for tighter GMO legislation and famously puts out annual "dirty dozen" list of fruits and ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be the prime mover behind the ongoing campaign against agricultural biotechnology at Consumer Reports. He is an ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend